Can focal therapy successfully control prostate cancer? Also, if so, which patients should be
considered eligible? With limited data available from relatively few patients, these questions
are difficult to answer. At this writing, the most likely candidates for focal therapy are patients
with low-risk, small-volume tumors, located in 1 region or sector of the prostate, who would
benefit from early intervention. The difficulty lies in reliably identifying these men. The larger
number of cores obtained in each needle biopsy session has increased both the detection of …